Compare SANJIVANI PA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANJIVANI PA vs SOLARA ACTIVE PHARMA SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANJIVANI PA SOLARA ACTIVE PHARMA SCIENCES SANJIVANI PA/
SOLARA ACTIVE PHARMA SCIENCES
 
P/E (TTM) x 8.3 19.9 41.5% View Chart
P/BV x - 2.5 - View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 SANJIVANI PA   SOLARA ACTIVE PHARMA SCIENCES
EQUITY SHARE DATA
    SANJIVANI PA
Mar-21
SOLARA ACTIVE PHARMA SCIENCES
Mar-21
SANJIVANI PA/
SOLARA ACTIVE PHARMA SCIENCES
5-Yr Chart
Click to enlarge
High Rs111,625 0.7%   
Low Rs6415 1.4%   
Sales per share (Unadj.) Rs29.5450.0 6.6%  
Earnings per share (Unadj.) Rs1.761.6 2.7%  
Cash flow per share (Unadj.) Rs2.791.8 2.9%  
Dividends per share (Unadj.) Rs07.00 0.0%  
Avg Dividend yield %00.7 0.0%  
Book value per share (Unadj.) Rs-52.8441.1 -12.0%  
Shares outstanding (eoy) m8.5035.93 23.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.32.3 12.7%   
Avg P/E ratio x5.116.6 30.6%  
P/CF ratio (eoy) x3.211.1 28.4%  
Price / Book Value ratio x-0.22.3 -6.9%  
Dividend payout %011.4 0.0%   
Avg Mkt Cap Rs m7236,648 0.2%   
No. of employees `000NANA-   
Total wages/salary Rs m212,294 0.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m25116,169 1.6%  
Other income Rs m3288 0.9%   
Total revenues Rs m25416,457 1.5%   
Gross profit Rs m213,859 0.6%  
Depreciation Rs m91,087 0.8%   
Interest Rs m1845 0.1%   
Profit before tax Rs m142,215 0.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m02 -4.7%   
Profit after tax Rs m142,214 0.6%  
Gross profit margin %8.523.9 35.7%  
Effective tax rate %-0.50.1 -747.7%   
Net profit margin %5.713.7 41.3%  
BALANCE SHEET DATA
Current assets Rs m9210,576 0.9%   
Current liabilities Rs m5767,888 7.3%   
Net working cap to sales %-193.016.6 -1,160.6%  
Current ratio x0.21.3 11.9%  
Inventory Days Days3614 262.6%  
Debtors Days Days96,433,75511 882,846,713.5%  
Net fixed assets Rs m10115,303 0.7%   
Share capital Rs m85359 23.7%   
"Free" reserves Rs m-53415,488 -3.4%   
Net worth Rs m-44915,847 -2.8%   
Long term debt Rs m531,548 3.4%   
Total assets Rs m19325,880 0.7%  
Interest coverage x12.23.6 337.0%   
Debt to equity ratio x-0.10.1 -120.9%  
Sales to assets ratio x1.30.6 208.4%   
Return on assets %8.011.8 67.8%  
Return on equity %-3.214.0 -22.6%  
Return on capital %-3.917.6 -22.1%  
Exports to sales %56.00-   
Imports to sales %3.80-   
Exports (fob) Rs m141NA-   
Imports (cif) Rs m10NA-   
Fx inflow Rs m1419,148 1.5%   
Fx outflow Rs m106,688 0.1%   
Net fx Rs m1312,460 5.3%   
CASH FLOW
From Operations Rs m61,555 0.4%  
From Investments Rs m-4-1,063 0.4%  
From Financial Activity Rs m-2925 -0.3%  
Net Cashflow Rs m-11,417 -0.1%  

Share Holding

Indian Promoters % 19.9 41.1 48.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 16.5 23.3 70.7%  
FIIs % 0.0 17.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 80.2 58.9 136.0%  
Shareholders   4,829 65,449 7.4%  
Pledged promoter(s) holding % 0.0 13.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANJIVANI PA With:   EMMESSAR CHM  COLINZ LABOR  ADESHWAR MEDITEX  SANOFI INDIA  CIAN HEALTHCARE  



Today's Market

Sensex Trades Lower Tracking Weak Global Cues; IT & Energy Stocks Under Pressure(10:30 am)

Asian share markets are trading mostly lower today with lingering worries over a US rate hike partly offset by potentially positive news on the severity of the Omicron coronavirus variant.

Related Views on News

SOLARA ACTIVE PHARMA SCIENCES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SOLARA ACTIVE PHARMA SCIENCES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SOLARA ACTIVE PHARMA SCIENCES. Also includes updates on the valuation of SOLARA ACTIVE PHARMA SCIENCES.

SOLARA ACTIVE PHARMA SCIENCES Announces Quarterly Results (1QFY22); Net Profit Up 18.5% (Quarterly Result Update)

Aug 5, 2021 | Updated on Aug 5, 2021

For the quarter ended June 2021, SOLARA ACTIVE PHARMA SCIENCES has posted a net profit of Rs 501 m (up 18.5% YoY). Sales on the other hand came in at Rs 4 bn (up 16.4% YoY). Read on for a complete analysis of SOLARA ACTIVE PHARMA SCIENCES's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANJIVANI PA SHARE PRICE


Dec 6, 2021 03:17 PM

TRACK SANJIVANI PA

  • Track your investment in SANJIVANI PA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANJIVANI PA 8-QTR ANALYSIS

COMPARE SANJIVANI PA WITH

MARKET STATS